PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis for 1/31/25
Copy link
Facebook
Email
Notes
More

Market Analysis for 1/31/25

SPY QQQ

PharmD_KS's avatar
PharmD_KS
Jan 30, 2025
∙ Paid
20

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis for 1/31/25
Copy link
Facebook
Email
Notes
More
1
Share

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord

The weekly post and video for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. Link to Market Analysis for The Week Ahead

Be sure you have read the Trading Doggy Style Starter Kit. I will be adding to this over time, likely first focusing on example executions. Trading Doggy Style Starter Kit. A recent update has been made with some additional content.

SPY 0.00%↑

Not a whole lot has changed as we continue to make higher highs and higher lows but still remain below the island gap on QQQ 0.00%↑ and have not yet filled the gap on SPY either. AAPL 0.00%↑ has just reported and the market has not moved much as of now (perhaps waiting for the call). We have PCE in the morning premarket.

Sellers have still done nothing, as dips (even this afternoon’s aggressive dip on Trump tariffs) have been firmly bought. That said, this isn’t a great location to initiate new (swing) longs.

We continue to see decent selling come in above 6100 on ES and above 21700 NQ. As long as bulls continue to defend dips it is reasonable to expect we get through this selling. A bullish response to PCE and gap up into the above ranges would be helpful to bulls. Remaining below these gaps keeps bulls somewhat at risk.

Trading Doggy Style with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More